Enter assignee name

EPO Patents = 2

Forward Citations = 8

Loading Chart...

14 inventors (with patents filed for the assignee):

Gregory Ian Frost (7 out of 8 patents)

James Joseph Onuffer, Jr (6 out of 7 patents)

Ghiabe H Guibinga (5 out of 5 patents)

4. Farzad Haerizadeh (5 out of 7 patents)

5. Anirban Kundu (2 out of 2 patents)

6. Anirban Kundu (2 out of 2 patents)

7. Hwai Wen Chang (1 out of 58 patents)

8. Gerhard Johann Frey (1 out of 87 patents)

9. Frederic Vigant (1 out of 1 patent)

10. Jay Milton Short (1 out of 179 patents)

11. Frederic Vigant (1 out of 1 patent)

12. Frederic Vigant (1 out of 1 patent)

13. James Joseph Onuffer (1 out of 1 patent)

14. Anirban Kundu (1 out of 1 patent)

15. James Joseph Onuffer Jr (0 patent)

7 patents: Sort by Forward Citations

1. 12590321 - METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING AND EXPANDING LYMPHOCYTES AND REGULATING THE ACTIVITY THEREOF (2026-03-31),

2. 12325728 - Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79B (2025-06-10),

3. 12258574 - Methods and compositions for transducing lymphocytes and regulating the activity thereof (2025-03-25),

4. 12187801 - Chimeric antigen receptors against AXL or ROR2 and methods of use thereof (2025-01-07),

5. 11325948 - Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL (2022-05-10),

6. 11111505 - Methods and compositions for transducing lymphocytes and regulating the activity thereof (2021-09-07),

7. 10596274 - Methods and compositions for transducing lymphocytes and regulated expansion thereof (2020-03-24),

Exuma Biotech Corp. is a pioneering biotechnology company focused on developing innovative therapies that address significant unmet medical needs. Specializing in gene and cell therapies, Exuma is dedicated to improving patient outcomes through cutting-edge research and technology. With a strong pipeline of products targeting various diseases, the company is committed to advancing the field of personalized medicine. The team comprises experts in biotechnology, medicine, and regulatory affairs, working collaboratively to bring transformative solutions to the market. Exuma Biotech strives to create a healthier future by harnessing the power of science and innovation.

This text is generated by artificial intelligence and may not be accurate.